Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Cytotoxin-associated gene A (CagA) and vacuolating cytotoxin A (VacA) are the keys to the pathogenic role of and the high-risk factors for the progression of gastric precancerous lesions. Autophagy can stabilize the intracellular environment, resist infection, prevent the accumulation of damaged DNA, and inhibit the proliferation of gastric precancerous variant cells. However, CagA and VacA can inhibit the activation of upstream signals of autophagy and the maturation of autophagy-lysosomes in various ways, thus inhibiting the autophagy of gastric mucosal cells in precancerous lesions of gastric cancer. This change can cause to be unable to be effectively cleared by autophagy, so CagA and VacA can persist and promote the inflammation, oxidative stress, apoptosis of gastric mucosal tissue cells, and the glycolytic activity and proliferation of variant cells in gastric precancerous lesions and a series of malignant biological processes. In recent years, the research on drugs specifically inhibiting the activities of CagA and VacA has become a new direction for the prevention and treatment of -related severe gastric diseases, and a variety of drugs or components that can precisely and effectively regulate the factors for the treatment of gastric precancerous lesions are emerged, which opens a new strategy for the treatment of gastric precancerous lesions in the future.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10930283PMC
http://dx.doi.org/10.11817/j.issn.1672-7347.2022.210779DOI Listing

Publication Analysis

Top Keywords

gastric precancerous
24
precancerous lesions
24
caga vaca
16
gastric mucosal
12
gastric
11
vaca inhibit
8
progression gastric
8
variant cells
8
treatment gastric
8
precancerous
7

Similar Publications

Purpose: Precancerous lesions of gastric cancer (PLGC) represent a crucial juncture in the transformation from gastritis to gastric cancer. Qijie Xiaopi Decoction (QJXPD), a Chinese herbal medicine formulation that has been applied in clinical practice to manage PLGC, which is capable of effectively relieving the symptoms experienced by patients such conditions. However, its mechanism of action remains unclear.

View Article and Find Full Text PDF

Background And Aims: The first international guideline for managing preneoplastic conditions of the stomach (MAPS I) was published in 2012, followed by an update (MAPS II) in 2019. As adherence to these guidelines remains uncertain, we evaluated adherence by comparing the management of preneoplastic gastric conditions before and after the introduction of MAPS I and II in selected European centers.

Methods: Patients data were retrieved from nine endoscopy units in seven European countries during three periods: pre-MAPS I (2010/2011), post-MAPS I (2017/2018), and post-MAPS II (2022/2023).

View Article and Find Full Text PDF

Gastric precancerous lesions (GPL) represent a crucial stage in the complex process of gastric carcinogenesis that leads to gastric cancer (GC), one of the most prevalent cancers and a major source of cancer mortality worldwide. Many studies have identified the gastrointestinal microbiota, or gut microbiota, as an important contributor to both the pathogenesis and treatment of GPL and GC, thus understanding its role in this transition is crucial. The purpose of this literature review is to introduce the current landscape of microbiota research associated with GPL and GC, with an emphasis on () driven microbial dysbiosis and its modulation through Western medicine and traditional Chinese medicine (TCM) approaches.

View Article and Find Full Text PDF

A 68-year-old man came to evaluate a gastric polyp discovered during a routine gastroscopy. After endoscopic mucosal resection, pathological findings confirmed that it's a hyperplastic polyp. Notably, squamous metaplasia was observed within the hyperplastic polyp, and both squamous and glandular epithelium exhibited high-grade intraepithelial neoplasia.

View Article and Find Full Text PDF

Huayu Xiaopi Decoction regulates the JNK/c-Jun/Slug pathway to inhibit epithelial-mesenchymal transformation and improve precancerous lesions of gastric cancer.

J Ethnopharmacol

August 2025

College of Traditional Chinese Medicine, Ningxia Medical University, Yinchuan, 750004, China; Ningxia Key Laboratory of Modernization of Minority Medicine, Yinchuan, 750004, China. Electronic address:

Ethnopharmacological Significance: Huayu Xiaopi Decoction (HYXPT), a traditional Chinese medicine formula, exhibits favorable therapeutic effects on precancerous lesions of gastric cancer (PLGC). However, a comprehensive characterization of its chemical constituents and absorbed components remains elusive, and the mechanisms underlying its efficacy in treating PLGC warrant further investigation.

Aim Of The Study: To explore the therapeutic effects and underlying mechanisms of HYXPT in the treatment of PLGC through an integrated approach combining bioinformatics analyses with in vivo and in vitro experiments.

View Article and Find Full Text PDF